Data From Two Studies Demonstrating Positive Financial Impact of INPEFA® (Sotagliflozin) to be Presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 National Meeting
Provided By GlobeNewswire
Last update: Oct 17, 2023
Abstracts for cost-effectiveness data and budget-impact model published in the Journal of Managed Care & Specialty Pharmacy (JMCP)
INPEFA recently approved by FDA for treatment of heart failure
Read more at globenewswire.com
